Discover

COR
Cencora, Inc.
257.82
1 x 257.50
1 x 257.85
bid
ask
-
2.69
1.03%
01:01 PM
timesize
Ytd -23.66%
1y -9.84%
256.57
day range
264.55
252.74
52 week range
374.75
Open 262.01 Prev Close 260.51 Low 256.57 High 264.55 Mkt Cap 50.16B
Vol 935.14K Avg Vol 1.60M EPS 13.06 P/E 19.74 Forward P/E 12.91
Beta 0.65 Short Ratio 3.08 Inst. Own 93.21% Dividend 2.40 Div Yield 0.92
Ex Div Date 05-15 Earning 08-05 50-d Avg 315.22 200-d Avg 327.21 1yr Est 357.00
Earning
Date For Estimate Reported Surprise surprise %
2026-05-06 2026-03 4.8 4.75 -0.05 -1.04%
2026-02-04 2025-12 4.07 4.08 0.01 0.25%
2025-11-05 2025-09 3.79 3.84 0.05 1.32%
2025-08-06 2025-06 3.78 4 0.22 5.82%
2025-05-07 2025-03 4.08 4.42 0.34 8.33%
2025-02-05 2024-12 3.5 3.73 0.23 6.57%
Upgrade / Downgrade
Date Firm Action From To
2026-05-11 Wells Fargo Upgrade Overweight Overweight
2026-05-07 UBS Upgrade Buy Buy
2026-05-07 Citigroup Upgrade Buy Buy
2026-05-07 Evercore ISI Group Upgrade Outperform Outperform
2026-05-07 Baird Upgrade Outperform Outperform
2026-04-28 William Blair Upgrade Market Perform
Profile
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; sales force services to manufacturers; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
Insider Holder
Date Name Relation Quantity Description
2026-03-10 BATTAGLIA SILVANA Officer 23.57K Conversion of Exercise of derivative security
2026-03-10 CAMPBELL ELIZABETH S Officer 30.71K Conversion of Exercise of derivative security
2026-03-10 CLEARY JAMES F. JR. Chief Financial Officer 160.36K Conversion of Exercise of derivative security
2025-09-15 COLLIS STEVEN H Officer and Director 305.91K Conversion of Exercise of derivative security
2026-03-04 DURCAN DERMOT MARK Director 23.77K Stock Award(Grant)
2026-03-04 GREENBERG LON R Director 18.41K Stock Award(Grant)
Institution Ownership
Report Date Organization Position Value Percentage
2026-03-30 Blackrock Inc. 19.94M 5.21B 10.25%
2025-12-30 State Street Corporation 9.31M 2.43B 4.78%
2025-12-30 Price (T.Rowe) Associates Inc 6.99M 1.83B 3.59%
2025-12-30 T. Rowe Price Investment Management, Inc. 6.70M 1.75B 3.44%
2025-12-30 Geode Capital Management, LLC 5.46M 1.43B 2.81%
2025-12-30 FMR, LLC 5.46M 1.43B 2.81%
Fund Ownership
Report Date Organization Position Value Percentage
2025-12-30 VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund 5.79M 1.51B 2.97%
2025-12-30 VANGUARD INDEX FUNDS-Vanguard 500 Index Fund 4.89M 1.28B 2.51%
2025-12-30 VANGUARD INDEX FUNDS-Vanguard Mid-Cap Index Fund 4.01M 1.05B 2.06%
2025-12-30 T. ROWE PRICE CAPITAL APPRECIATION Fd., INC.-T. Rowe Price Capital App 2.73M 711.99M 1.40%
2026-01-30 VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund 2.63M 687.34M 1.35%
2026-03-30 iShares Trust-iShares Core S&P 500 ETF 2.50M 652.69M 1.28%
Dividend
Dividend Date
0.6 2026-05-15
0.6 2026-02-13
0.6 2025-11-14
0.55 2025-08-15
0.55 2025-05-16
0.55 2025-02-14
Split
Split Date
10 : 1 2014-06-13